EP2680834 - SEMISOLID AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING TAPENTADOL [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 24.08.2018 Database last updated on 20.07.2024 | |
Former | The patent has been granted Status updated on 15.09.2017 | ||
Former | Grant of patent is intended Status updated on 10.05.2017 | Most recent event Tooltip | 17.07.2020 | Lapse of the patent in a contracting state New state(s): AL | published on 19.08.2020 [2020/34] | Applicant(s) | For all designated states Grünenthal GmbH Zieglerstrasse 6 52078 Aachen / DE | [2017/42] |
Former [2014/02] | For all designated states Grünenthal GmbH Zieglerstrasse 6 52078 Aachen / DE | Inventor(s) | 01 /
REINHOLD, Ulrich I. Rote-Haag Weg 44a 52076 Aachen / DE | 02 /
SCHILLER, Marc Max-Pechstein-Strasse 4 52076 Aachen / DE | 03 /
WULSTEN, Eva Bonnenring 188 47877 Willich / DE | 04 /
INGHELBRECHT, Sabine, Karine, Katrien c/o Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 Beerse / BE | 05 /
EMBRECHTS, Roger, Carolus, Augusta c/o Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 Beerse / BE | 06 /
FEIL, Ulrich Berliner Allee 17 63739 Aschaffenburg / DE | [2014/02] | Representative(s) | Bülle, Jan, et al Kutzenberger Wolff & Partner Waidmarkt 11 50676 Köln / DE | [N/P] |
Former [2014/02] | Bülle, Jan, et al Kutzenberger Wolff & Partner Theodor-Heuss-Ring 23 50668 Köln / DE | Application number, filing date | 12710026.1 | 02.03.2012 | [2017/42] | WO2012EP00906 | Priority number, date | US201161449329P | 04.03.2011 Original published format: US 201161449329 P | EP20110003603 | 03.05.2011 Original published format: EP 11003603 | [2014/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012119729 | Date: | 13.09.2012 | Language: | EN | [2012/37] | Type: | A1 Application with search report | No.: | EP2680834 | Date: | 08.01.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.09.2012 takes the place of the publication of the European patent application. | [2014/02] | Type: | B1 Patent specification | No.: | EP2680834 | Date: | 18.10.2017 | Language: | EN | [2017/42] | Search report(s) | International search report - published on: | EP | 13.09.2012 | Classification | IPC: | A61K31/137, A61K9/06, A61K47/14 | [2017/18] | CPC: |
A61K31/137 (EP,KR,US);
A61K9/06 (KR,US);
A61K47/06 (US);
A61K47/10 (KR,US);
A61K47/14 (EP,KR,US);
A61K9/0014 (EP,KR,US);
|
Former IPC [2017/17] | A61K31/137, A61K9/06, A61K47/06, A61K47/10, A61K47/14 | ||
Former IPC [2014/02] | A61K31/137, A61K9/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/02] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | HALBFESTE WÄSSRIGE PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT TAPENTADOL | [2014/02] | English: | SEMISOLID AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING TAPENTADOL | [2014/02] | French: | COMPOSITION PHARMACEUTIQUE AQUEUSE SEMI-SOLIDE CONTENANT DU TAPENTADOL | [2014/02] | Entry into regional phase | 04.10.2013 | National basic fee paid | 04.10.2013 | Designation fee(s) paid | 04.10.2013 | Examination fee paid | Examination procedure | 04.10.2013 | Examination requested [2014/02] | 02.04.2014 | Amendment by applicant (claims and/or description) | 11.05.2017 | Communication of intention to grant the patent | 08.09.2017 | Fee for grant paid | 08.09.2017 | Fee for publishing/printing paid | 08.09.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | EP17189139.3 / EP3290029 | EP20188822.9 / EP3766489 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 11.05.2017 | Opposition(s) | 19.07.2018 | No opposition filed within time limit [2018/39] | Fees paid | Renewal fee | 12.03.2014 | Renewal fee patent year 03 | 10.03.2015 | Renewal fee patent year 04 | 10.03.2016 | Renewal fee patent year 05 | 10.03.2017 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 18.10.2017 | MK | 18.10.2017 | SM | 18.10.2017 | [2020/34] |
Former [2020/31] | MK | 18.10.2017 | |
SM | 18.10.2017 | ||
Former [2018/40] | SM | 18.10.2017 | Cited in | International search | [IA]WO02067651 (GRUENENTHAL GMBH [DE], et al) [I] 1,2,4-8,10-15 * page 2, paragraph 1; examples 7,8 * [A] 3,9; | [AD]WO2007128412 (GRUENENTHAL GMBH [DE], et al) [AD] 1-15* the whole document *; | [IDA]WO2008110323 (GRUENENTHAL GMBH [DE], et al) [ID] 1,2,4-8,10-15 * page 15, line 14 - page 16, line 9; example 5 * [A] 3,9; | [IA]US2010272815 (KHUNT MAYUR DEVJIBHAI [IN], et al) [I] 1,2,4-8,10-15 * paragraph [0091] * [A] 3,9; | [A] - TZSCHENTKE T M ET AL, "Tapentadol hydrochloride. Analgesic, Mu-opioid receptor agonist, noradrenaline reuptake inhibitor.", DRUGS OF THE FUTURE, (200612), vol. 31, no. 12, ISSN 0377-8282, pages 1053 - 1061, XP002660111 [A] 1-15 * the whole document * | by applicant | WO02067651 | WO03035053 | WO2006002886 | WO2007128412 | WO2007128413 | WO2008110323 | WO2009067703 | WO2009092601 | US2010272815 | - T.M. TZSCHENTKE ET AL., DRUGS OF THE FUTURE, (2006), vol. 12, pages 1053 - 1061 | - C.Y. HO ET AL., AM J RHINOL., (2008), vol. 22, no. 2, pages 125 - 9 | - HONG ET AL., CURR OPIN ALLERGY CLIN IMMUNOL., (2009), vol. 9, no. 5, pages 447 - 53 | - M.G. SONI ET AL., FOOD CHEM TOXICOL., (2001), vol. 39, no. 6, pages 513 - 32 | - S. OISHI, FOOD CHEM TOXICOL., (2002), vol. 40, no. 12, pages 1807 - 13 | - M.G. SONI ET AL., FOOD CHEM TOXICOL., (2005), vol. 43, no. 7, pages 985 - 015 |